Lumexa Imaging Holdings, Inc. (LMRI)

Market Cap	895.74M
Revenue (ttm)	1.02B +7.8%
Net Income	-47.10M
EPS	-0.66
Shares Out	96.11M
PE Ratio	n/a
Forward PE	12.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	518,361
Open	9.26
Previous Close	9.30
Day's Range	9.00 - 9.62
52-Week Range	7.23 - 19.45
Beta	n/a
Analysts	Strong Buy
Price Target	22.67 (+143.24%)
Earnings Date	May 18, 2026

About LMRI

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 11, 2025
• Employees: 4,335
• Stock Exchange: NASDAQ
• Ticker Symbol: LMRI
• Website: https://www.lumexaimaging.com

Financial Performance

In 2025, Lumexa Imaging Holdings's revenue was $1.02 billion, an increase of 7.82% compared to the previous year's $948.87 million. Losses were -$47.10 million, -49.94% less than in 2024.

Analyst Summary

According to 4 analysts, the average rating for LMRI stock is "Strong Buy." The 12-month stock price target is $22.67, which is an increase of 143.24% from the latest price.

Price Target

$22.67

(143.24% upside)

Analyst Consensus: Strong Buy